DailyUpdates was launched in 2002 by the pharmaceutical analysts LeadDiscovery and represents the first "newsfeed" that identifies breaking scientific publications with drug development potential. Using proprietary data retrieval strategies LeadDiscovery selects daily 1,000 PubMed articles and press releases.  The selected articles and releases are then scanned by an industrial research panel which judges those articles considered to be of greatest benefit for the drug development sector. Selected publications as well as press releases are then listed on DailyUpdates six therapeutic channels that match core R&D areas; Oncology Channel; CNS disorders; Cardiovascular disease; Metabolic and Hormonal disorders; Immunology, Inflammation & Infection; Internal Medicine.

Subscription to this service is $95.00/year per channel.  From the day of your subscription you will receive daily email bulletins (see Oncology sample below) specific to your selected channel delivering:

• key journal articles selected by LeadDiscovery's panel of industrial R&D experts

• press releases as they are distributed announcing news on clinical trials, regulatory approvals and product launches

• information on new pharmaceutical reports offering in-depth analysis of your therapeutic area.

To subscribe - click here!

LeadDiscovery Reports - click here